BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Emtricitabine (Emtriva) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Emtricitabine (Emtriva)\, from ClinicalTr
 ials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07792096-9911@assetmemo.bio
DTSTAMP:20261121T005002Z
DTSTART;VALUE=DATE:20290630
DTEND;VALUE=DATE:20290701
SUMMARY:Emtricitabine (Emtriva): Phase 3 readout est. (NCT07792096)
DESCRIPTION:Emtricitabine (Emtriva)\, phase 3\, HIV.\nStudy: An Adaptive Pl
 atform Trial for Evaluation of Novel Treatment Regimens in Children and Ad
 olescents With HIV in Africa\nEstimated primary completion: June 2029. Thi
 s is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it
  can move.\nDrug page: https://assetmemo.bio/drug/emtricitabine-emtriva#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT077920
 96
URL:https://assetmemo.bio/drug/emtricitabine-emtriva#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
